ARCHIVES

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

This article is from The Cancer Letter archive.

Vol. 10 No. 14 | April 6, 1984

Download PDF Visit The Full Archive

Related Articles

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

NCI Considering Proposal To Form “Drug Discovery Cooperative Groups”; Concept To DCT Board In June

February 26, 1982

DCT Board Approves Concept To Recomplete Data Management Contract

June 29, 1984

NCAB to Review Coding of Projects Addressing Minorites and Undeserved

February 19, 1999

Abstracts Of Papers From Therapeutic Radiology Meeting

November 21, 1975

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980